Douglas Miehm Analyst PerformanceAnalyst at Royal Bank Of CanadaDouglas Miehm is a stock analyst at Royal Bank Of Canada in the medical sector, covering 9 publicly traded companies. Over the past year, Douglas Miehm has issued 17 stock ratings, including buy and hold recommendations. While full access to Douglas Miehm's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Douglas Miehm's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions. Analyst Rankings, Coverage, and Performance StatisticsAnalyst RankingSubscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeatAverage Return00.00% 12-Month ROISuccess Rate00.00% Profitable RatingsTotal Ratings71 Last 11 YearsBuy Recommendations48.57% 34 Buy RatingsCompanies Covered9 Unique Companies Ratings Distribution70RatingsDistribution of strong buy, buy, hold, and sell ratings by Douglas Miehm.RatingPercentageCount Strong Buy0.0%0 ratings Buy48.6%34 ratings Hold51.4%36 ratings Sell0.0%0 ratingsOut of 70 total stock ratings issued by Douglas Miehm at Royal Bank Of Canada, the majority (51.4%) have been Hold recommendations, followed by 48.6% Buy.Best & Worst CallsBest Call000.0%AUPHDec 2019Subscribe to MarketBeat All Access to get analyst recommendation ROI.Worst Call000.0%BHCJul 2015Subscribe to MarketBeat All Access to get analyst recommendation ROI.Exchange CoverageExchangePercentageCountNASDAQ55.6% of companies on NASDAQ5 companiesNYSE22.2% of companies on NYSE2 companiesTSE11.1% of companies on TSE1 companyOTCMKTS11.1% of companies on OTCMKTS1 companyDouglas Miehm, an analyst at Royal Bank Of Canada, currently covers 9 companies listed on NASDAQ, NYSE, TSE and OTCMKTS, with the majority traded on NASDAQ.Coverage FocusSector IconSectorPercentageMedical9 companies100.0%Douglas Miehm of Royal Bank Of Canada specializes in stock coverage within the Medical sector.Coverage IndustriesIndustryPercentageMED - BIOMED/GENE4 companies44.4%MED - GENERIC DRG1 company11.1%MEDICAL SERVICES1 company11.1%MED - DRUGS1 company11.1%MEDICAL INSTRUMENTS & SUPPLIES1 company11.1%PHARMACEUTICAL PREPARATIONS1 company11.1% Douglas Miehm's Ratings History at Royal Bank Of Canada Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Timeframe Start Date End Date All Ratings Strong Buy Buy Hold Sell Rating Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.Available with a MarketBeat All Access Subscription12-Month ROIUpgrade to All Access to use the All ROI Filter Export CompanyReport DateActionReport Date Price12-MonthPrice TargetRating12-MonthPrice & ROIDetailsLGNDLigand Pharmaceuticals5/8/2026Boost Price Target$219.55$262.00Outperform$0.0000.00% ROIMNKDMannKind5/7/2026Boost Price Target$3.61$4.75Sector Perform$0.0000.00% ROIPCRXPacira BioSciences5/1/2026Boost Price Target$24.15$24.00Sector Perform$0.0000.00% ROILGNDLigand Pharmaceuticals4/28/2026Boost Price Target$238.78$252.00Outperform$0.0000.00% ROIBHCBausch Health Cos4/27/2026Lower Price Target$5.71$9.00Sector Perform$0.0000.00% ROIMNKDMannKind2/27/2026Reiterated Rating$3.24$3.50Sector Perform$0.0000.00% ROIBLCOBausch + Lomb1/27/2026Boost Price Target$16.91$21.00Outperform$0.0000.00% ROILGNDLigand Pharmaceuticals12/10/2025Boost Price Target$187.43$235.00Outperform$0.0000.00% ROIBLCOBausch + Lomb11/14/2025Boost Price Target$15.47$19.00Outperform$0.0000.00% ROIMNKDMannKind11/11/2025Lower Price Target$5.27$7.50Outperform$0.0000.00% ROILGNDLigand Pharmaceuticals11/10/2025Boost Price Target$201.57$234.00Outperform$0.0000.00% ROIAUPHAurinia Pharmaceuticals11/5/2025Reiterated Rating$14.27$15.00Sector Perform$0.0000.00% ROIMNKDMannKind8/26/2025Boost Price Target$3.95$8.00Outperform$0.0000.00% ROILGNDLigand Pharmaceuticals8/8/2025Boost Price Target$150.84$185.00Outperform$0.0000.00% ROIMNKDMannKind8/7/2025Lower Price Target$3.42$7.00Outperform$0.0000.00% ROIAUPHAurinia Pharmaceuticals8/1/2025Boost Price Target$10.01$9.00Outperform$0.0000.00% ROIMNKDMannKind7/23/2025Lower Price Target$3.93$8.00Outperform$0.0000.00% ROIBHCBausch Health Cos5/2/2025Boost Price Target$5.45$10.00Sector Perform$0.0000.00% ROIBLCOBausch + Lomb4/4/2025Lower Price Target$12.32$17.00Outperform$00.0000.00% ROIONCYOncolytics Biotech3/10/2025Lower Price Target$0.66$5.00Outperform$0.0000.00% ROIBLCOBausch + Lomb2/20/2025Lower Price Target$16.11$18.00Outperform$00.0000.00% ROIBHCBausch Health Cos1/30/2025Lower Price Target$7.41$10.00Sector Perform$0.0000.00% ROIBLCOBausch + Lomb1/29/2025Lower Price Target$17.79$22.00Outperform$00.0000.00% ROI Stock Forecasts and Research Tools Today's Analyst Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Top Stock Recommendations by BrokerageWall Street ZenJefferies Financial GroupWeiss RatingsUBS GroupCitigroupBarclaysWells Fargo & CompanyMorgan StanleyRoyal Bank Of CanadaJPMorgan Chase & Co.The Goldman Sachs GroupTD CowenTruist FinancialPiper SandlerStifel Nicolaus Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
